No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
Multiple sclerosis (MS) is a complex neurological disease with huge variability in disease outcome. The majority of MS genetic susceptibility is determined by major histocompatibility complex (MHC) alleles, in particular haplotypes carrying HLA-DRB1*1501. HLA-DRB1*1501 also affects the clinical outc...
Main Authors: | Handel, A, De Luca, G, Morahan, J, Handunnetthi, L, Sadovnick, A, Ebers, G, Ramagopalan, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
by: Handunnetthi, L, et al.
Published: (2010) -
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
by: Ramagopalan, S, et al.
Published: (2010) -
Re: HLA-DRB1 and multiple sclerosis in Malta.
by: Ramagopalan, S, et al.
Published: (2008) -
Parental transmission of HLA-DRB1*15 in multiple sclerosis.
by: Ramagopalan, S, et al.
Published: (2008) -
HLA-DRB1 and Month-of-Birth in Multiple Sclerosis
by: Ebers, G, et al.
Published: (2009)